Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pallansch

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|April 1, 1994
Enterovirus 71 infections and neurologic disease--United States, 1977-1991J P Alexander, L Baden, M A Pallansch, et al.
The New England Journal of Medicine|September 9, 1993
Vaccine-associated paralytic poliomyelitisL Mermel, D Sanchez de Mora, R W Sutter, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 18, 2000
Serotype-specific identification of enterovirus 71 by PCRB A Brown, D R Kilpatrick, M S Oberste, et al.
Journal of Virology|January 1, 1980
Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirusO M Kew, M A Pallansch, D R Omilianowski, et al.
Virology|October 1, 1987
Geographic distribution of wild poliovirus type 1 genotypesR Rico-Hesse, M A Pallansch, B K Nottay, et al.
Journal of Medical Virology|April 1, 1987
Diagnosis of enterovirus 70 infection by demonstration of IgM antibodiesH Wulff, L J Anderson, M A Pallansch, et al.
Diabetes|February 1, 1997
The role of enteroviral infections in the development of IDDM: limitations of current approachesP M Graves, J M Norris, M A Pallansch, et al.
The Journal of Infectious Diseases|February 1, 1997
Comparison of a monoclonal antibody-based IgM capture ELISA with a neutralization assay for assessing response to trivalent oral poliovirus vaccineH E Gary, C Freeman, S Peñaranda, et al.
Virus Research|July 1, 1991
Detection and identification of vaccine-related polioviruses by the polymerase chain reactionC F Yang, L De, B P Holloway, et al.
Annals of the New York Academy of Sciences|May 31, 1995
Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccinationR W Sutter, M A Pallansch, L A Sawyer, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|April 1, 1994
Enterovirus 71 infections and neurologic disease--United States, 1977-1991J P Alexander, L Baden, M A Pallansch, et al.
The New England Journal of Medicine|September 9, 1993
Vaccine-associated paralytic poliomyelitisL Mermel, D Sanchez de Mora, R W Sutter, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 18, 2000
Serotype-specific identification of enterovirus 71 by PCRB A Brown, D R Kilpatrick, M S Oberste, et al.
Journal of Virology|January 1, 1980
Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirusO M Kew, M A Pallansch, D R Omilianowski, et al.
Virology|October 1, 1987
Geographic distribution of wild poliovirus type 1 genotypesR Rico-Hesse, M A Pallansch, B K Nottay, et al.
Journal of Medical Virology|April 1, 1987
Diagnosis of enterovirus 70 infection by demonstration of IgM antibodiesH Wulff, L J Anderson, M A Pallansch, et al.
Diabetes|February 1, 1997
The role of enteroviral infections in the development of IDDM: limitations of current approachesP M Graves, J M Norris, M A Pallansch, et al.
The Journal of Infectious Diseases|February 1, 1997
Comparison of a monoclonal antibody-based IgM capture ELISA with a neutralization assay for assessing response to trivalent oral poliovirus vaccineH E Gary, C Freeman, S Peñaranda, et al.
Virus Research|July 1, 1991
Detection and identification of vaccine-related polioviruses by the polymerase chain reactionC F Yang, L De, B P Holloway, et al.
Annals of the New York Academy of Sciences|May 31, 1995
Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccinationR W Sutter, M A Pallansch, L A Sawyer, et al.
Pageof 8